{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:37:01Z","timestamp":1770817021478,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>New psychoactive substances have been rapidly growing in popularity in the drug market as non-illegal drugs. In the last few years, an increment has been reported on the use of synthetic alternatives to heroin, the synthetic opioids. Based on the information provided by the European Monitoring Centre for Drug and Drug Addiction, these synthetic opioids have been related to overdoses and deaths in Europe and North America. One of these opioids is the U-47700. A few months ago, U-47700 was scheduled in the U.S. and other countries, and other opioid derivatives have been appearing in order to replace it. One of these compounds is U-49900, an analog of U-47700. A white powder sample was obtained from an anonymous user in Spain. After an accurate characterization by gas chromatography-mass spectrometry, ultra-high performance liquid chromatography-high resolution mass spectrometry, nuclear magnetic resonance and single-crystal X-ray diffraction; and complemented by Fourier-transformed infrared spectroscopy, ultraviolet and circular dichroism spectrophotometry, the drug sample was unequivocally identified as U-49900. The information provided will be useful for the Early Warning System and forensic laboratories for future identifications of the U-49900, as well as in tentative identifications of other related opioids.<\/jats:p>","DOI":"10.1038\/s41598-017-06778-9","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T14:56:18Z","timestamp":1500389778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900)"],"prefix":"10.1038","volume":"7","author":[{"given":"D.","family":"Fabregat-Safont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Carb\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Forn\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Guillam\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. V.","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"6778_CR1","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/add.12287","volume":"108","author":"P Griffiths","year":"2013","unstructured":"Griffiths, P., Evans-Brown, M. & Sedefov, R. Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction \n                           108, 1700\u20131703 (2013).","journal-title":"Addiction"},{"key":"6778_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/dta.1686","volume":"6","author":"SD Brandt","year":"2014","unstructured":"Brandt, S. D., King, L. A. & Evans-Brown, M. The new drug phenomenon. Drug Test. Anal. \n                           6, 587\u2013597 (2014).","journal-title":"Drug Test. Anal."},{"key":"6778_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11419-016-0310-4","volume":"34","author":"M Katselou","year":"2016","unstructured":"Katselou, M., Papoutsis, I., Nikolaou, P., Spiliopoulou, C. & Athanaselis, S. Old opioids, new concerns: the case of acetylfentanyl. Forensic Toxicol. \n                           34, 201\u2013212 (2016).","journal-title":"Forensic Toxicol."},{"key":"6778_CR4","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2016. EMCDDA\u2013Europol Jt. Publ. 80, doi:10.2810\/88175 (2016).","DOI":"10.2810\/88175"},{"key":"6778_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/15563650.2014.943908","volume":"52","author":"A Helander","year":"2014","unstructured":"Helander, A., B\u00e4ckberg, M. & Beck, O. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin. Toxicol. \n                           52, 901\u2013904 (2014).","journal-title":"Clin. Toxicol."},{"key":"6778_CR6","unstructured":"Harper, N. J. & Veitch, G. B. A. 1-(3,4-dichlororbenzamidomethyl)-cyclohexyldimethylamine. Patent No. US3975443A. Allen & Hanburys Limited, London, England (1976)."},{"key":"6778_CR7","doi-asserted-by":"crossref","unstructured":"Kjellgren, A. & Jacobsson, K. The Quest for Well-Being and Pleasure: Experiences of the Novel Synthetic Opioids AH-7921 and MT-45, as Reported by Anonymous Users Online. J. Addict. Res. Ther. 7 (2016).","DOI":"10.4172\/2155-6105.1000287"},{"key":"6778_CR8","unstructured":"Szmuszkovicz, J. Analgesic N-(2-aminocycloaliphatic)benzamides. Patent No. US4098904A. The Upjohn Company, Michigan, USA (1978)."},{"key":"6778_CR9","unstructured":"Novel opioid, U-47700-Mega Thread and FAQ. Date accessed 2017-02-23. bluelight.org (2014). Available at: http:\/\/bluelight.org\/vb\/threads\/739960-Novel-opioid-U-47700-Mega-Thread-and-FAQ. (Accessed: 23rd February 2017)."},{"key":"6778_CR10","unstructured":"Department of Justice. Drug Enforcement Administration (DEA). Schedules of Controlled Substances: Temporary Placement of U-47700 Into Schedule I. Federal Register 81 (173) 61636\u201361638 (2016). Available at: https:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2016\/fr1114.htm."},{"key":"6778_CR11","unstructured":"World Health Organization. U-47700 Critical Review Report. 38th Expert Committee on Drug Dependence, convened from 14 to 18 November 2016, at WHO headquarters in Geneva. 38th Expert Comm. Drug Depend. 14\u201318 (2016)."},{"key":"6778_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/dta.1984","volume":"8","author":"SP Elliott","year":"2016","unstructured":"Elliott, S. P., Brandt, S. D. & Smith, C. The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis. Drug Test. Anal. \n                           8, 875\u2013879 (2016).","journal-title":"Drug Test. Anal."},{"key":"6778_CR13","first-page":"1","volume":"3650","author":"K Domanski","year":"2016","unstructured":"Domanski, K. et al. Two cases of intoxication with new synthetic opioid, U-47700. Clin. Toxicol. \n                           3650, 1\u20135 (2016).","journal-title":"Clin. Toxicol."},{"key":"6778_CR14","first-page":"1","volume":"3650","author":"MJ Jones","year":"2016","unstructured":"Jones, M. J., Hernandez, B. S., Janis, G. C. & Stellpflug, S. J. A case of U-47700 overdose with laboratory confirmation and metabolite identification. Clin. Toxicol. \n                           3650, 1\u20135 (2016).","journal-title":"Clin. Toxicol."},{"key":"6778_CR15","first-page":"1","volume":"3650","author":"A Schneir","year":"2016","unstructured":"Schneir, A., Metushi, I. G., Sloane, C., Benaron, D. J. & Fitzgerald, R. L. Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class. Clin. Toxicol. \n                           3650, 1\u20134 (2016).","journal-title":"Clin. Toxicol."},{"key":"6778_CR16","unstructured":"Commision on Narcotic Drugs Extract from the Report of the 38th Expert Committee on Drug Dependence, convened from 14 to 18 November 2016, at WHO headquarters in Geneva. Annex 1. 38th Expert Comm. Drug Depend. 10192 (2016)."},{"key":"6778_CR17","unstructured":"U-47700. Date accessed 2017-02-23. psychonautwiki.org Available at: https:\/\/psychonautwiki.org\/wiki\/U-47700. (Accessed: 23rd February 2017)."},{"key":"6778_CR18","unstructured":"Novel opioid U-51754. Date accessed 2017-02-23. bluelight.org (2016). Available at: http:\/\/www.bluelight.org\/vb\/threads\/793107-Novel-opioid-U-51754. (Accessed: 23rd February 2017)."},{"key":"6778_CR19","doi-asserted-by":"publisher","unstructured":"Fabregat-Safont, D. et al. Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain. Drug Test. Anal., doi:10.1002\/dta.2182 (2017).","DOI":"10.1002\/dta.2182"},{"key":"6778_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00216-015-9237-6","volume":"408","author":"\u00c9 Alechaga","year":"2016","unstructured":"Alechaga, \u00c9., Moyano, E. & Galceran, M. T. Ion-molecule adduct formation in tandem mass spectrometry. Anal. Bioanal. Chem. \n                           408, 1269\u20131277 (2016).","journal-title":"Anal. Bioanal. Chem."},{"key":"6778_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1107\/S0021889808042726","volume":"42","author":"OV Dolomanov","year":"2009","unstructured":"Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. \n                           42, 339\u2013341 (2009).","journal-title":"J. Appl. Crystallogr."},{"key":"6778_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1107\/S0021889807029238","volume":"40","author":"L Palatinus","year":"2007","unstructured":"Palatinus, L. & Chapuis, G. SUPERFLIP - A computer program for the solution of crystal structures by charge flipping in arbitrary dimensions. J. Appl. Crystallogr. \n                           40, 786\u2013790 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"6778_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S0108767307043930","volume":"64","author":"GM Sheldrick","year":"2007","unstructured":"Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. Sect. A Found. Crystallogr. \n                           64, 112\u2013122 (2007).","journal-title":"Acta Crystallogr. Sect. A Found. Crystallogr."},{"key":"6778_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1107\/S0108767395007367","volume":"51","author":"RC Clark","year":"1995","unstructured":"Clark, R. C. & Reid, J. S. The analytical calculation of absorption in multifaceted crystals. Acta Crystallogr. Sect. A Found. Crystallogr. \n                           51, 887\u2013897 (1995).","journal-title":"Acta Crystallogr. Sect. A Found. Crystallogr."},{"key":"6778_CR25","unstructured":"Brandenburg, K. & Putz, H. DIAMOND. Cryst. Impact GbR, Bonn, Ger. (1999)."},{"key":"6778_CR26","unstructured":"U-47700 P.S.A. Date accessed 2017-02-23. reddit.com (2016). Available at: https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/3yc7hr\/u47700_psa\/. (Accessed: 23rd February 2017)."},{"key":"6778_CR27","unstructured":"Anyone else have infections, abscesses from IV\u2019ing U47700? Date accessed 2017-02-23. reddit.com (2016). Available at: https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/4kt9jk\/anyone_else_have_infections_abscesses_from_iving. (Accessed: 23rd February 2017)."},{"key":"6778_CR28","unstructured":"U-49900 - Experiment and Warning. Date accessed 2017-02-23. reddit.com (2016). Available at: https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/5gbo3e\/u49900_experiment_and_warning. (Accessed: 23rd February 2017)."},{"key":"6778_CR29","unstructured":"U-49900 - New Op RC. Date accessed 2017-02-23. reddit.com (2016). Available at: https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/5e1bzy\/u49900_new_op_rc. (Accessed: 23rd February 2017)."},{"key":"6778_CR30","unstructured":"Ny RC opiat U-49000 [U-49900]. Date accesses 2017-02-23. flashback.org (2016). Available at: https:\/\/www.flashback.org\/t2785232p2. (Accessed: 23rd February 2017)."},{"key":"6778_CR31","unstructured":"Nishimura, H. et al. 1-substituted-4-(1,2-diphenylethyl)-piperazine derivatives and their salts and the preparation thereof. Patent No. US3957788A. Dainippon Pharmaceutical Co., Ltd., Osaka, Japan. 77 (1976)."},{"key":"6778_CR32","unstructured":"MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine). Date accessed 2017-02-23. bluelight.org (2012). Available at: http:\/\/www.bluelight.org\/vb\/threads\/640564-MT-45-(1-cyclohexyl-4-(1-2-diphenylethyl)piperazine. (Accessed: 23rd February 2017)"},{"key":"6778_CR33","unstructured":"Government of the United Kingdom. A change to the Misuse of Drugs Act 1971: control of MT-45 and 4,4\u2032-DMAR. Date accessed 2017-02-23. gov.uk (2015). Available at: https:\/\/www.gov.uk\/government\/publications\/circular-0032015-a-change-to-the-misuse-of-drugs-act-1971-control-of-mt-45-and-44-dmar\/a-change-to-the-misuse-of-drugs-act-1971-control-of-mt-45-and-44-dmar. (Accessed: 23rd February 2017)."},{"key":"6778_CR34","unstructured":"U-49900 HCL from lsresearchchemlab.com. Date accessed 2017-02-23. lsresearchchemlab.com Available at: http:\/\/www.lsresearchchemlab.com\/u-49900-hcl.html. (Accessed: 23rd February 2017)."},{"key":"6778_CR35","unstructured":"Interview with a Ketamine Chemist. Date accessed 2017-02-23. vice.com (2011). Available at: https:\/\/www.vice.com\/en_us\/article\/interview-with-ketamine-chemist-704-v18n2. (Accessed: 23rd February 2017)."},{"key":"6778_CR36","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/dta.1620","volume":"6","author":"H Morris","year":"2014","unstructured":"Morris, H. & Wallach, J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test. Anal. \n                           6, 614\u2013632 (2014).","journal-title":"Drug Test. Anal."},{"key":"6778_CR37","unstructured":"Centers for Disease Control and Prevention. Increases in Fentanyl Drug Confiscations and Fentanyl-related Overdose Fatalities. Accessed 2017-02-23. emergency.cdc.gov (2015). Available at: https:\/\/emergency.cdc.gov\/han\/han00384.asp. (Accessed: 23rd February 2017)"},{"key":"6778_CR38","unstructured":"Centers for Disease Control and Prevention. Increases in Fentanyl-Related Overdose Deaths \u2014 Florida and Ohio, 2013\u20132015. Accessed 2017-02-23. cdc.gov (2016). Available at: Increases in Fentanyl-Related Overdose Deaths \u2014 Florida and Ohio, 2013\u20132015. (Accessed: 23rd February 2017)."},{"key":"6778_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s13181-015-0477-9","volume":"11","author":"MJ Lozier","year":"2015","unstructured":"Lozier, M. J. et al. Acetyl Fentanyl, a Novel Fentanyl Analog, Causes 14 Overdose Deaths in Rhode Island, March\u2013May 2013. J. Med. Toxicol. \n                           11, 208\u2013217 (2015).","journal-title":"J. Med. Toxicol."},{"key":"6778_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.annemergmed.2016.08.445","volume":"69","author":"SN Lucyk","year":"2017","unstructured":"Lucyk, S. N. & Nelson, L. S. Novel Synthetic Opioids: An Opioid Epidemic Within an Opioid Epidemic. Ann. Emerg. Med. \n                           69, 91\u201393 (2017).","journal-title":"Ann. Emerg. Med."},{"key":"6778_CR41","first-page":"1","volume":"7077","author":"J Tournebize","year":"2016","unstructured":"Tournebize, J., Gibaja, V. & Kahn, J.-P. Acute effects of synthetic cannabinoids: Update 2015. Subst. Abus. \n                           7077, 1\u201323 (2016).","journal-title":"Subst. Abus."},{"key":"6778_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnbeh.2011.00060","volume":"5","author":"L Fattore","year":"2011","unstructured":"Fattore, L. & Fratta, W. Beyond THC: The New Generation of Cannabinoid Designer Drugs. Front. Behav. Neurosci. \n                           5, 1\u201312 (2011).","journal-title":"Front. Behav. Neurosci."},{"key":"6778_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa1610300","volume":"376","author":"AJ Adams","year":"2017","unstructured":"Adams, A. J. et al. \u2018Zombie\u2019 Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York. N. Engl. J. Med. \n                           376, 235\u2013242 (2017).","journal-title":"N. Engl. J. Med."},{"key":"6778_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00216-015-9088-1","volume":"408","author":"M Ib\u00e1\u00f1ez","year":"2016","unstructured":"Ib\u00e1\u00f1ez, M. et al. Analytical strategy to investigate 3,4-methylenedioxypyrovalerone (MDPV) metabolites in consumers\u2019 urine by high-resolution mass spectrometry. Anal. Bioanal. Chem. \n                           408, 151\u2013164 (2016).","journal-title":"Anal. Bioanal. Chem."},{"key":"6778_CR45","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00216-013-7595-5","volume":"406","author":"J Welter","year":"2014","unstructured":"Welter, J., Meyer, M. R., Kavanagh, P. & Maurer, H. H. Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MS n. Anal. Bioanal. Chem. \n                           406, 1957\u20131974 (2014).","journal-title":"Anal. Bioanal. Chem."},{"key":"6778_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jms.2960","volume":"47","author":"MR Meyer","year":"2012","unstructured":"Meyer, M. R., Vollmar, C., Schwaninger, A. E., Wolf, E. U. & Maurer, H. H. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J. Mass Spectrom. \n                           47, 253\u2013262 (2012).","journal-title":"J. Mass Spectrom."},{"key":"6778_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugpo.2016.10.006","volume":"40","author":"P Quintana","year":"2017","unstructured":"Quintana, P. et al. The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin. Int. J. Drug Policy \n                           40, 78\u201383 (2017).","journal-title":"Int. J. Drug Policy"},{"key":"6778_CR48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jms.3217","volume":"48","author":"M Iba\u00f1ez","year":"2013","unstructured":"Iba\u00f1ez, M. et al. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends. J. Mass Spectrom. \n                           48, 685\u2013694 (2013).","journal-title":"J. Mass Spectrom."},{"key":"6778_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.trac.2014.02.009","volume":"57","author":"M Iba\u00f1ez","year":"2014","unstructured":"Iba\u00f1ez, M. et al. Comprehensive analytical strategies based on high-resolution time-of-flight mass spectrometry to identify new psychoactive substances. TrAC - Trends Anal. Chem. \n                           57, 107\u2013117 (2014).","journal-title":"TrAC - Trends Anal. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06778-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:23:23Z","timestamp":1671780203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06778-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06778-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6338"}}